TomoTherapy to Present at Three Upcoming Investment Conferences
Lazard Capital Markets Radiation Oncology Conference on June 9; Needham Life Sciences Conference on June 10; William Blair Growth Stock Conference on June 10
MADISON, Wis – June 4, 2009 – TomoTherapy Incorporated (NASDAQ: TOMO) today announced that management will participate in three investment community conferences in early June.
On Tuesday, June 9, 2009, Gustavo Olivera, Ph.D., vice president of research, and Shawn Guse, vice president of international operations, will present at the Lazard Capital Markets Radiation Oncology Conference at 9:15 a.m. EDT. The conference is being held at Le Parker Meridien hotel in New York City, NY.
Olivera and Guse will also present at the 8th Annual Needham Life Sciences Conference on Wednesday, June 10, 2009 at 9:00 a.m. EDT. The conference takes place at the New York Palace hotel in New York City, NY.
On Wednesday, June 10, 2009, Steve Hathaway, CFO, and Del Coufal, vice president of marketing, will present at William Blair’s 29th Annual Growth Stock Conference at 2:40 p.m. CDT. The conference is being held at the Four Seasons Hotel in Chicago, Ill.
Live Webcasts of the Needham and William Blair conference presentations will be available on the investor relations page of TomoTherapy.com. For those who are unable to listen to the live presentations, archives of the Webcasts will be available on the company’s site for 30 days following the presentation. The Lazard Capital Markets presentation is not being Webcast.
About TomoTherapy Incorporated
TomoTherapy Incorporated develops, markets and sells advanced radiation therapy solutions that can be used to treat a wide variety of cancers, from the most common to the most complex. The ring gantry-based TomoTherapy® platform combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. TomoTherapy’s suite of solutions include its flagship Hi·Art® treatment system, which has been used to deliver more than three million CT-guided, helical intensity-modulated radiation therapy (IMRT) treatment fractions; the TomoHD™ treatment system, designed to enable cancer centers to treat a broader patient population with a single device; and the TomoMobile™ relocatable radiation therapy solution, designed to improve access and availability of state-of-the-art cancer care. TomoTherapy’s stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.
4 Jun 2009
| Investor Contact: Thomas E. Powell Chief Financial Officer 608.824.2800 tpowell@tomotherapy.com |
Media Contact: Kevin O’Malley Manager Corporate Communications 608.824.2800 komalley@tomotherapy.com |
